Annual SG&A
$0.00$8.60B-100.00%
Summary
- Current Value
- As of today, TMO annual SG&A is $0.00, down -100.00% on
- Historical Performance
- TMO annual SG&A is down -100.00% over the past 3 years, down -100.00% over the past 5 years
- All-Time High Comparison
- TMO annual SG&A is currently -100.00% below its historical high of $8.99B set on
- 3-Year Low Comparison
- TMO annual SG&A vs 3-year low value is unknown
- Sector Comparison
- TMO annual SG&A is higher than 42.01% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $1.98B | +7.1% | +7.7% | +10.3% | +175.4% | |
| TTM SG&A | - | – | – | – | – | |
| Price | $513.56 | -3.3% | -8.2% | +7.3% | +790.4% | |
| Annual Operating Expenses | $8.67B | -13.9% | -17.3% | +6.6% | +188.0% | |
| Annual Operating Profit | $8.11B | +5.8% | -4.9% | +2.7% | +541.3% | |
| Annual D&A | $2.78B | -10.6% | -17.8% | +19.6% | +275.8% | |
| Annual Revenue | $44.56B | +3.9% | -0.8% | +38.3% | +328.7% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $8.99B | N/A | -100.0% |
| 5Y | $8.99B | -100.0% | |
| All | $8.99B | -100.0% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
SG&A History
FAQ
What is the current annual SG&A of TMO?
As of today, TMO annual SG&A is $0.00
What is 1-year change in TMO annual SG&A?
TMO annual SG&A is down -100.00% year-over-year
What is 3-year change in TMO annual SG&A?
TMO annual SG&A is down -100.00% over the past 3 years
How far is TMO annual SG&A from its all-time high?
TMO annual SG&A is currently -100.00% below its historical high of $8.99B set on December 31, 2022
How does TMO annual SG&A rank versus sector peers?
TMO annual SG&A is higher than 42.01% of companies in Healthcare sector
When is TMO next annual earnings release?
As of today, the next annual earnings release for TMO has not been scheduled
Quarterly SG&A
$1.98B$185.00M-8.56%
Summary
- Current Value
- As of today, TMO quarterly SG&A is $1.98B, down -8.56% on
- Historical Performance
- TMO quarterly SG&A is up +7.10% year-over-year, up +7.68% over the past 3 years
- All-Time High Comparison
- TMO quarterly SG&A is currently -13.18% below its historical high of $2.28B set on
- 3-Year Low Comparison
- TMO quarterly SG&A is +18.24% above its 3-year low of $1.67B reached on
- Sector Comparison
- TMO quarterly SG&A is higher than 98.75% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $1.98B | -8.6% | +7.1% | +7.7% | +10.3% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | - | – | – | – | – | |
| Price | $513.56 | -10.5% | -3.3% | -8.2% | +7.3% | |
| Quarterly Operating Expenses | $2.33B | -4.3% | +6.1% | +7.5% | +8.5% | |
| Quarterly Operating Profit | $2.30B | +6.9% | +1.5% | +16.0% | -26.6% | |
| Quarterly D&A | $728.00M | +10.1% | -1.9% | -14.2% | +20.9% | |
| Quarterly Revenue | $12.22B | +9.8% | +7.2% | +6.7% | +15.8% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.16B | -8.6% | |
| 3Y | $2.18B | -9.4% | |
| 5Y | $2.28B | -13.2% | |
| All | $2.28B | -13.2% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.85B | N/A | +7.1% |
| 3Y | $1.67B | +18.2% | |
| 5Y | $1.67B | +18.2% | |
| All | -$92.40M | +2239.6% |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of TMO?
As of today, TMO quarterly SG&A is $1.98B
What is TMO quarterly SG&A most recent change?
TMO quarterly SG&A was down -8.56% on December 31, 2025
What is 1-year change in TMO quarterly SG&A?
TMO quarterly SG&A is up +7.10% year-over-year
How far is TMO quarterly SG&A from its all-time high?
TMO quarterly SG&A is currently -13.18% below its historical high of $2.28B set on March 1, 2022
How does TMO quarterly SG&A rank versus sector peers?
TMO quarterly SG&A is higher than 98.75% of companies in Healthcare sector
When is TMO next earnings release?
The next earnings release for TMO is on
TTM SG&A
N/A
Summary
- Status
- TMO TTM SG&A is unknown
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | - | – | – | – | – | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $1.98B | -8.6% | +7.1% | +7.7% | +10.3% | |
| Price | $513.56 | -10.5% | -3.3% | -8.2% | +7.3% | |
| TTM Operating Profit | $8.24B | +0.4% | +7.8% | -3.3% | +4.0% | |
| TTM D&A | $2.78B | -0.5% | -10.6% | -17.8% | +19.6% | |
| TTM Revenue | $44.56B | +1.9% | +3.9% | -0.8% | +38.3% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $220.80B | N/A | N/A |
| 3Y | $220.80B | N/A | N/A |
| 5Y | $220.80B | N/A | N/A |
| All | $220.80B | N/A | N/A |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $203.01B | N/A | N/A |
| 3Y | $158.96B | N/A | N/A |
| 5Y | $100.47B | N/A | N/A |
| All | $45.80M | N/A | N/A |
TTM SG&A History
FAQ
What is the current TTM SG&A of TMO?
TMO TTM SG&A is unknown
What is TMO TTM SG&A most recent change?
TMO TTM SG&A change on December 31, 2025 is unknown
What is 1-year change in TMO TTM SG&A?
TMO TTM SG&A 1-year change is unknown
How far is TMO TTM SG&A from its all-time high?
TMO TTM SG&A vs all-time high is unknown
When is TMO next earnings release?
The next earnings release for TMO is on
Selling, General & Administrative Expenses Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Data Sources & References
- TMO Official Website www.thermofisher.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/97745/000009774526000012/0000097745-26-000012-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/97745/000009774526000012/0000097745-26-000012-index.htm
- TMO Profile on Yahoo Finance finance.yahoo.com/quote/TMO
- TMO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tmo